Abstract submission is now open for JADPRO Live 2022, taking place October 20 to 23 in Aurora, Colorado, and includes a new poster track: APSHO Patient/Advocacy Perspective Posters. This track provides patients and patient advocates a platform to share perspectives on their care with over 1,500 oncology advanced practitioners. JADPRO Live is an annual educational conference that brings together oncology advanced practitioners, including nurse practitioners, physician assistants, pharmacists, and advanced degree nurses, to collaborate on the latest advances in cancer care.
JADPRO Live is also the setting for the annual member meeting of the Advanced Practitioner Society for Hematology and Oncology (APSHO), an organization of over 4,000 members. The mission of APSHO is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology.
Oncology advanced practitioners often build strong partnerships with their patients and become deeply attuned to their patients’ wishes, values, and needs. The inaugural poster track is an opportunity for advocacy organizations, patients, and clinicians to encourage a collaborative approach to key components of patient care, such as communication, education, symptom management, and caregiver support.
“The collective voices of patients and advocacy groups, together with clinician perspectives, will provide a powerful narrative highlighting the patient journey,” commented the President of APSHO, Sandra E. Kurtin, PhD, ANP-C, AOCN®, of Arizona Cancer Center.
Patients and advocacy partners will present their findings during moderated poster sessions scheduled throughout the conference. Posters will be available to registered conference attendees via the conference app, a dedicated area for viewing onsite, and an e-poster gallery on the JADPRO Live website. This track is made possible by the Founding Supporter, Pfizer Oncology.
Patients and advocacy groups interested in submitting an abstract for consideration can visit jadprolive.com/abstracts.The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.